FindTrial
Sign In

Effects of oral antidiabetic drugs and glucagon-like peptide-1 receptor agonists on left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus

Effects of oral antidiabetic drugs and glucagon-like peptide-1 receptor agonists on left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus - Effects of oral antidiabetic drugs and glucagon-like peptide-1 receptor agonists on left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000036923
Enrollment
500
Registered
2019-06-04
Start date
2019-06-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

None listed

Sponsors

Ise Red Cross Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Type 2 diabetic patients who receive oral antidiabetic drugs or glucagon-like peptide-1 receptor agonists

Exclusion criteria

Exclusion criteria: type 1 diabetes secondary diabetes pregnant

Design outcomes

Primary

MeasureTime frame
left ventricular diastolic dysfunction—

Countries

Japan

Contacts

Public Contactsatoshi ida

Ise Red Cross Hospital Department of diabetes and metabolism

bboy98762006@yahoo.co.jp0596282171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026